Blog
Sermorelin Side Effects and When to Contact Support
Sermorelin side effects reported in clinical studies are mostly local and short-lived: pain, swelling or redness at the injection site, facial flushing, and headache. In the prescribing information for Geref, the FDA-approved sermorelin product sold until 2008, a local injection reaction was the most common treatment-related event, reported in about one in six children in the trials, and every other event occurred in fewer than one in a hundred.
That record comes from children treated for growth hormone deficiency, because that is the only use the FDA ever approved. The adult studies are small and short. This guide sets out the sermorelin side effects the label and the research found, what the growth hormone guidelines add, how an AHC customer should handle each symptom, and which signs mean contacting support or seeking care.
| Key points Sermorelin is a synthetic fragment of growth hormone releasing hormone that prompts the pituitary to release the body’s own growth hormone, and it clears from the blood within minutes. The documented side effects are injection site reactions, flushing, headache and, in diagnostic use, nausea. No long-term safety data exist in adults, and today’s sermorelin is a compounded product that is not FDA-approved. |
Table of Contents
What Sermorelin Is and Why It Has Side Effects
Sermorelin is a synthetic copy of the first 29 amino acids of growth hormone releasing hormone, the shortest piece that keeps the full activity of the natural hormone. A 1999 review in BioDrugs describes how it acts on the anterior pituitary, which then releases growth hormone in the body’s own pattern, and that pattern explains most sermorelin side effects.
| Fact | What the research says | Why it shapes side effects |
| Mechanism | Stimulates the pituitary rather than supplying growth hormone directly | Effects follow the body’s own release, with the feedback loops intact |
| Half-life | Cleared from the blood within minutes per the original label and a 1994 study in ten men | Most effects are brief and tied to the injection itself |
| Route | Given by injection under the skin | Local reactions are the most common event |
| Antibodies | Many treated children developed antibodies to the peptide in the original trials | The label called the significance unclear |
| Approval history | Approved in 1990 for diagnosis and 1997 for treatment in children, withdrawn in 2009 after the maker stopped selling it | The safety record stops at the pediatric trials |
The FDA stated in 2013 that Geref was not withdrawn for reasons of safety or effectiveness. No FDA-approved sermorelin product exists today, and the sermorelin in the AHC longevity program is a compounded medication, so sermorelin side effects in adults on compounded products have never been formally studied. Our explainer on what sermorelin is covers the history in more detail.
What Are Common Side Effects of Sermorelin Injections?
The common sermorelin side effects are local injection reactions, flushing and headache. The figures below come from the Geref prescribing information as reproduced from its 2001 revision, so they describe children on the approved product rather than adults on a compounded one.
| Side effect | How often in the original trials | What it felt like |
| Injection site reaction | About one in six treated patients | Pain, swelling or redness at the site |
| Headache | Fewer than one in a hundred | Usually brief |
| Flushing | Fewer than one in a hundred | Warmth and redness of the face |
| Dizziness or sleepiness | Fewer than one in a hundred | Passing |
| Hyperactivity | Fewer than one in a hundred | Reported in children |
| Hives or difficulty swallowing | Fewer than one in a hundred | Reported rarely, no generalized allergic reactions in the trials |
When sermorelin was given into a vein as a diagnostic test, the label listed facial flushing, injection site pain, nausea, headache, vomiting, a change in taste, pallor and chest tightness. Those came with a rapid intravenous dose and do not describe home injection. The 1999 BioDrugs review summed up sermorelin side effects the same way: transient facial flushing and pain at the injection site were the most commonly reported events.
What Research Shows About Sermorelin Side Effects in Adults
Adult studies of sermorelin and its close relatives are few, small and short, and none reported serious harm within their weeks of follow-up. That is reassuring as far as it goes, and it does not go far.
| Study and design | Who took part | What researchers found |
| 1992, Journal of Clinical Endocrinology and Metabolism. Two 14-day treatment periods | 10 healthy men around 68, with 9 young men as comparison | No change in fasting glucose, blood pressure or blood chemistry |
| 1997, Metabolism. Open study, six weeks of nightly injections | 11 healthy men aged 64 to 76 | No significant adverse effects observed |
| 1997, Journal of Clinical Endocrinology and Metabolism. Placebo lead-in, then 16 weeks of a closely related GHRH analog | 19 adults aged 55 to 71, 10 of them women | The only adverse effect was a temporary rise in blood fats that resolved by the end |
| 2026, Frontiers in Endocrinology. Narrative review | Published peptide studies | Injection site pain, short-term flushing, nausea, dizziness and headache. No long-term safety data available |
Open study means no placebo group, and the 1997 trial used a modified version of the molecule rather than sermorelin itself. The 2026 review, from Poznan University of Medical Sciences with no external funding, also notes a theoretical cancer concern from growth hormone signaling with no established clinical signal, and states that benefits in healthy people remain uncertain. These studies describe sermorelin side effects in a few dozen people over a few weeks, which is the honest size of the evidence.
What the Growth Hormone Guidelines Add
Sermorelin works by raising the body’s own growth hormone, so the effects endocrinologists watch for with growth hormone treatment belong on any list of possible sermorelin side effects. They come from guidelines on growth hormone replacement, not from sermorelin studies.
- Fluid retention. The Endocrine Society’s 2011 guideline lists tingling, joint stiffness, swelling of the hands and feet, joint pain and muscle aches as the most common effects of growth hormone treatment in adults.
- Carpal tunnel syndrome. Listed in both the 2011 Endocrine Society and 2019 American Association of Clinical Endocrinologists guidelines.
- Blood sugar. Both guidelines note worsening glucose tolerance with growth hormone treatment.
- Active cancer. Both guidelines list active malignancy as a contraindication to growth hormone treatment.
- Anti-aging use. The 2019 guideline states that growth hormone should never be prescribed for sports or anti-aging purposes, and that no studies have tested long-term safety for that use.
A 2007 systematic review in Annals of Internal Medicine pooled 31 articles on growth hormone in healthy older adults and found more soft tissue swelling, joint pain, carpal tunnel syndrome and breast tissue growth in men than on placebo. These findings are about growth hormone itself at replacement doses. Sermorelin raises growth hormone less directly and the feedback loop stays in place, but nobody has studied whether that changes the risk list, which is why AHC makes no claim that it does.
Sermorelin Side Effects During Treatment at AHC
At AHC, every sermorelin side effect goes to AHC support, never to a pharmacy. Most of what people report is the injection site, and the table sorts the rest by what to do.
| What you notice | What it may reflect | What to do at AHC |
| Sore, red or swollen spot at the injection site | The most common event in the original trials | Rotate sites, keep new sites an inch apart, and tell support if it lasts more than a few days |
| Warm flushed face after injecting | Documented flushing, usually brief | Note it in your log and mention it at your next review |
| Headache in the hours after a dose | Listed in the label at under one in a hundred | Fluids and rest. Contact support if it repeats with every dose |
| Swollen hands or feet, tingling, stiff joints | Effects described with rising growth hormone | Contact support through live chat or email for a medical officer review |
| Unusual thirst, frequent urination or blurred vision | Possible change in blood sugar control | Contact support promptly and see a clinician for a glucose check |
Dose changes are never automatic. Contact AHC support through live chat on the website or at [email protected], and AHC’s medical officer reviews any request. The original label noted that steroid medicines such as prednisone may blunt the response and that an untreated underactive thyroid can reduce it, so list every medication and condition on your intake. Results vary by individual and depend on adherence, clinical guidance, and lifestyle factors.
| About compounded medication Compounded sermorelin is prepared by state-licensed pharmacy partners held to the same quality and safety standards. It is not FDA-approved and has not been reviewed by the FDA for safety, efficacy or quality. |
How to Reduce Injection Site Reactions
Injection site reactions are the sermorelin side effects you can do something about. The steps follow MedlinePlus guidance on subcutaneous injections.
- Choose healthy skin. No redness, swelling, bruising or scarring at the site.
- Rotate every time. Upper arms, outer thighs or the belly away from the navel, with each new site at least an inch from the last.
- Let the alcohol dry. Injecting through wet alcohol stings.
- Keep the vial stored correctly. Our guide to storing longevity injectables covers the fridge and travel.
- Press, do not rub. Hold clean gauze on the site for a few seconds afterward.
- Expect mild soreness. MedlinePlus calls some soreness at the site expected.
- Log each injection. Date, site and any reaction, so patterns show before your next review.
Our post on sermorelin therapy in the first weeks covers what else to expect early on, including which sermorelin side effects tend to fade.
| Thinking about the longevity program? Learn how the AHC longevity program works. You complete a medical intake and pay online, then an AHC provider reviews it and decides whether treatment fits your health history. |
When Sermorelin Side Effects Need Medical Attention
A few symptoms are not routine sermorelin side effects and need prompt attention. MedlinePlus and the endocrine guidelines name them.
| Sign | Why it matters |
| Spreading redness, swelling, red streaks or a fever around an injection site | Signs of infection per MedlinePlus. Contact your care team |
| Hives, swelling of the face or lips, or trouble breathing | Possible allergic reaction. Seek emergency care |
| Severe or persistent headache with vision changes | The guidelines note raised pressure inside the skull with growth hormone treatment, rare in adults. Seek care |
| New or worsening numbness in the hands | Carpal tunnel syndrome is listed in both guidelines. Contact support |
| A new lump, unexplained bleeding or a cancer diagnosis | Growth hormone treatment is contraindicated in active cancer. Stop and contact support and your doctor |
Contact AHC support through live chat or email for anything on this list that is not an emergency, and seek medical care first for anything that is. You can also speak with an AHC provider for $29.99 about whether sermorelin fits your health history.
Frequently Asked Questions
What are the most common sermorelin side effects?
Injection site pain, swelling or redness, reported in about one in six children in the original trials. Headache, flushing and dizziness were each reported in fewer than one in a hundred.
Are sermorelin side effects different in women?
The adult studies were too small to compare sermorelin side effects between sexes. The 1997 trial of a related analog included 10 women and reported only a temporary rise in blood fats across the whole group.
Does sermorelin cause nausea?
Nausea appeared among sermorelin side effects for intravenous diagnostic use, not for injections under the skin. If it happens with home injections, note it and tell AHC support.
How do I report sermorelin side effects at AHC?
Report sermorelin side effects through AHC support, by live chat on the website or at [email protected]. Support routes it to the medical officer, and customers never contact the pharmacy.
Will AHC change my sermorelin plan because of side effects?
You can request a review through support for any sermorelin side effects. The medical officer reviews it based on your response and symptoms, and nothing changes automatically.
Is the sermorelin at AHC FDA-approved?
No. The FDA-approved product was withdrawn in 2009 after its maker stopped selling it. AHC’s sermorelin is compounded, and compounded medications are not FDA-approved.
Does sermorelin at AHC cause the side effects of growth hormone injections?
AHC makes no claim either way. The fluid retention and joint symptoms come from growth hormone replacement guidelines, and no study has tested whether sermorelin carries the same risks.
Should I tell my AHC provider about steroids or thyroid medication?
Yes. The original label noted that glucocorticoid steroids may blunt the response and that untreated hypothyroidism can reduce it. List every medication on your intake.
Can I take sermorelin alongside GLP-1 treatment at AHC?
That decision belongs to your AHC provider, who reviews your full history on the intake. AHC makes no claim that combining products does more than either alone.
Can I speak with an AHC provider about sermorelin side effects?
Yes. A provider consultation costs $29.99 and is a good place to discuss symptoms, your history and whether the longevity program fits you.
Tools to Plan Your Next Step
Two free tools give you baseline numbers to bring to a provider conversation about sermorelin side effects or anything else.
- TDEE calculator. Estimate your daily energy needs so your routine stays steady.
- Visceral fat calculator. Record a starting estimate from waist and height, without any implication that a longevity product changes it.
Speak with an AHC provider for $29.99 about sermorelin side effects and whether the program fits you.
Sources
- Federal Register, 2009 and 2013. Geref withdrawal and FDA determination. Government record.
- Geref prescribing information, 2001 revision. As reproduced. Regulatory document.
- BioDrugs, 1999. Review of sermorelin in children.
- Journal of Clinical Endocrinology and Metabolism, 1992, 1994 and 1997. GHRH fragment studies in adults.
- Metabolism, 1997. Nightly GHRH in elderly men.
- Frontiers in Endocrinology, 2026. Review of growth hormone axis peptides.
- Journal of Clinical Endocrinology and Metabolism, 2011. Endocrine Society adult growth hormone guideline.
- Endocrine Practice, 2019. AACE growth hormone deficiency guideline.
- Annals of Internal Medicine, 2007. Systematic review of growth hormone in healthy elderly.
- MedlinePlus, 2025. Subcutaneous injection instructions. Government source.
- FDA compounding pages, 2026. Bulk substance lists. Government source.
Medical Disclaimer
This content is for informational purposes only and is not medical advice. Compounded medications are prepared by state-licensed pharmacy partners. They are not FDA-approved and have not been reviewed by the FDA for safety, efficacy or quality. Prescriptions are issued by independently contracted, U.S.-licensed clinicians following an individual medical review, and approval is never guaranteed. Results vary by individual and depend on adherence, clinical guidance, and lifestyle factors. For questions about your treatment, contact AHC support through live chat on the website or at [email protected]. If you have severe symptoms, seek medical care.